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Summary. The purpose of this study was to compare the
effects of five different cryopreservation protocols on the
histology of bioengineered tissues. Although several
artificial tissues have been developed to the date by
tissue engineering, classical histological analysis
methods and techniques must be optimized for these new
tissues with special properties. The results of this study
showed that the use of volatile solutions (formaldehyde,
glutaraldehyde, glacial acetic acid and acetone) was not
able to prevent the formation of large ice crystals that, in
turn, can alter the structure of the artificial tissues.
However, preincubation of the tissues in different
concentrations of a carbon hydrate (glucose, maltose or
trehalose) resulted in a better preservation of the tissue
structure. We conclude that the best protocol that allows
for an efficient analysis of the bioengineered tissues with
very few artifacts is preincubation of the tissues in
0.300M or 0.400M trehalose for 30 or 120 min prior to
OCT (optimal cutting temperature) embedding and
cryosectioning. For all those reasons, we recommend the
use of a cryoprotective agent before OCT embedding of
human artificial tissues.
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Introduction
Construction of artificial organs by tissue
engineering is one of the research fields that has
experienced major progress during recent years (Atala,
2000). By using tissue engineering techniques, several
researchers have developed different artificial organs
and tissues with therapeutic potential using diverse
biomaterials as stroma substitutes. Biomaterials should
imitate, in most part, the extracellular matrix of the
desired structure and organ function (Li et al., 2002;
Boland et al., 2004), including adequate resistance and
support (Bruder and Fox, 1999), control of bioactive
molecule liberation, biocompatibility and biodegradable
properties (Hutmacher et al., 2001).
In this regard, our research group has developed a
novel stromal substitute made of a mixture of human
fibrin and agarose type VII that has demonstrated
appropriate biomechanical and structural properties
when used for tissue engineering purposes, including the
successful generation of oral mucosa and corneas
(Alaminos et al., 2006, 2007; Sanchez-Quevedo et al.,
2007). Once the artificial substitutes are generated,
histological analysis is an important part of the
evaluation process and quality control of the artificial
tissues developed by tissue engineering. Moreover,
histological analysis technique has to be accurate and
sensitive and the image obtained under the microscope
must be real and free from artifacts. 
In this context, one of the most rapid techniques that
allows an efficient preservation of most of the protein
epitopes to facilitate proteomic analysis, such as
immunological assays, is the cryoprocessing of tissues
embedded in OCT (optimal cutting temperature) (Naber
et al., 1992; Rahimi et al., 2006). Cryoprocessing of
tissue samples embedded in OCT has several advantages
over paraffin embedding, especially the rapidness of the
procedure and the maintenance of the structure and
biochemical composition of the tissue. However, OCT
technique must be optimized for certain tissue types that
have high contents of water and low physical resistance
to strength, as is the case of tissues generated in the
laboratory by tissue engineering. For that reason, the use
of cryotechniques could generate false histological
images with a high number of artifacts, mainly due to
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the formation of large crystals of ice that, in turn, may
alter or even destroy the structure of the bioengineered
tissue. 
To avoid the formation of large water crystals, the
use of certain cryoprotective agents has been suggested
(Barthel and Raymond, 1990; Naber et al., 1992; Loken
and Demetrick, 2005). For that reason, in this work, we
have carried out a cryostat histological analysis on
human tissue substitutes developed by tissue engineering
using different cryofixation protocols in order to identify
an accurate method for the analysis of this kind of
artificial tissue.
Materials and methods
Fabrication of fibrin-agarose tissue constructs
Human fibrin was obtained from frozen plasma of
human blood donors (kindly provided by Dr. Fernandez-
Montoya, Human Tissue Bank of Granada). To produce
a scaffold by tissue engineering (Alaminos et al., 2006,
2007; Sanchez-Quevedo et al., 2007) 21 ml of human
plasma were added to 2 ml of DMEM with 10% FCS. To
prevent degradation of the scaffold by fibrinolysis, the
mixture was supplemented with 200 µl of tranexamic
acid. Then, 2 ml of 1% CaCl2 were added to the solution
to precipitate fibrin polymerization. Finally, type VII
agarose was melted and dissolved in PBS and added to
the fibrin mixture at a final concentration of 0.1%,
immediately after the CaCl2 was added. The mixture
was seeded in Petri dishes and allowed to solidify at
37°C for 2 hours.
Cryoprotection protocols for histological analysis of fibrin-
agarose scaffolds
Fibrin-agarose scaffolds were cut into small pieces
of approximately 0.5x0.5x0.25 cm and each piece was
preincubated in a different cryoprotective agent for
different times before being embedded in OCT
compound (Tissue-Tek) and cryofixed at liquid nitrogen
temperature. OCT compound is a formulation of water-
soluble glycols and resins, providing a convenient
specimen matrix for cryostat sectioning at temperatures
of -10°C and below. As a control, one group of samples
was fixed for 2 h in 4% formalin and embedded in
paraffin following standard procedures. Briefly, fixed
samples were washed in water and dehydrated in graded
ethanol series (50, 70, 96 and 100%). Then, the ethanol
was substituted by toluene and the samples were cleared
three times in xylene. Finally, samples were included in
liquid paraffin and 4 µm sections were obtained using a
microtome.
The specific groups of study included in this work
are the following: 1) samples included in OCT without
any previous cryoprotective procedure. 2) samples
preincubated in a volatile agent (acetone, acetic acid,
formaldehyde or glutaraldehyde) for 60 min before OCT
embedding. 3) samples preincubated in a 0.002M,
0.020M, 0.050M, 0.080M, 0.100M, 0.200M, 0.300M or
0.400M solution of glucose for 30, 60 or 120 min before
OCT embedding. 4) samples preincubated in a 0.002M,
0.020M, 0.050M, 0.080M, 0.100M, 0.200M, 0.300M or
0.400M solution of maltose for 30, 60 or 120 min before
OCT embedding. 5) samples preincubated in a 0.002M,
0.020M, 0.050M, 0.080M, 0.100M, 0.200M, 0.300M or
0.400M solution of trehalose for 30, 60 or 120 min
before OCT embedding. Three different tissue samples
were incubated in each group of study.
The concentration used for acetone and acetic acid
was 100%, whereas formaldehyde was used at 4% and
glutaraldehyde concentration was 3%. All concentrations
of glucose, maltose and trehalose were prepared in
distilled water at room temperature. 
Once incubated in the different cryoprotective
solutions, all samples were embedded in OCT compound
(Sakura Finetek USA) and cryofixed at liquid nitrogen
temperature. Then, five micron-sections were obtained
by using a cryostat microtome at -20º C, placed on
microscope slides and stained with hematoxylin and
eosin using standard methods. Finally, the structure of
the artificial tissues was evaluated by quantifying the
average area and diameter of the interfibrillar spaces
generated within the fiber mesh using the software NIS-
AR 301E with an ECLIPSE Ti light microscope (Nikon
Ltd., Tokio, Japan). In brief, 10 images were taken from
each sample using 200x magnifications, and all spaces
allocated within the artificial tissues were detected using
the automatic mode of the software. This software
allows for the automatic identification of all empty
spaces in each image and, therefore, the possibility of
errors or biases is minimized. Once detected, the area
and diameter of 10 spaces were calculated for each
image. Average area and diameter of all spaces analyzed
in this work were 6938.6 µm2 and 69.3 µm, respectively.
Statistical analysis
To compare the average areas and diameters of the
samples submitted to each cryopreservation protocol
with the control paraffin-embedded tissues, we used the
non-parametric test U of Mann-Whitney. For each
comparison, a Bonferroni-adjusted two-sided
significance level of 0.001 was considered, because up
to more than 50 statistical tests were used at the same
time. Comparisons with p value of 0.001 were
considered as marginally significant, whereas values
higher than 0.001 were considered as non-significant. To
carry out the previously described statistical analysis, we
used SPSS 13.0 software.
Results
Histological analysis of formalin-fixed paraffin-embedded
control samples
As controls, artificial tissues were fixed in formalin
and embedded in paraffin. The use of this standard
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technique showed good results, with proper preservation
of the structure and architecture of the fiber mesh of the
artificial matrix (Fig. 1A), allowing for an adequate
sectioning and staining of the artificial tissues. The mean
area and diameter of the spaces that appeared among the
mesh fibers of the artificial tissues were very small, with
44.4±25.2 µm2 and 7.2±2.3 µm, respectively (Table 1).
Histological analysis of untreated, OCT-embedded
artificial tissues
The structure and architecture of the artificial tissue
observed with this procedure showed poor results,
characterized by a disorganization of the fiber mesh and
the presence of holes, gaps and fissures among the mesh
fibers, with a mean area of 8557.7±7273.9 µm2 and a
mean diameter of 95.5±44.4 µm, much higher than that
observed in formalin-fixed, paraffin-embedded control
tissues (p<0.001). In addition, sample cryosectioning
was difficult to perform, and generation of 5 µ m-
thickness sections of these tissues was complicated due
to a loose consistency of the tissues (Fig. 1B).
Histological analysis of samples pretreated with acetone,
glacial acetic acid, formaldehyde or glutaraldehyde and
embedded in OCT 
Artificial tissues pretreated with acetone, glacial
acetic acid, formalin or glutaraldehyde and embedded in
OCT at liquid nitrogen temperature, were difficult to
manage using the cryostat. In fact, generation of 5 µm-
thickness cryosections of these tissues was very
complicated due to the lack of consistency of these
tissues. Furthermore, the artificial tissues were highly
disorganized, with the presence of large holes, gaps and
fissures whose areas were 322.5, 453.9, 356.7 and 368.1
times higher in comparison with the formalin-fixed,
paraffin-embedded tissues (Table 1). Differences were
statistically significant for both the area and the diameter
of the artificial tissues (p<0.001). Illustrative examples
of bioengineered tissues processed with these techniques
are shown in Figure 1 C-F.
Histological analysis of samples pretreated with glucose,
maltose or trehalose and embedded in OCT
Glucose
In the first place, artificial tissues incubated in
0.002M, 0.020M, 0.050M, 0.080M, 0.100M, 0.200M,
0.300M and 0.400M glucose as a cryoprotective solution
for 30 min had very low consistency, with high spaces
1533
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Table 1. Results of the histological analysis of formalin-fixed paraffin-embedded human control artificial tissues, samples embedded in OCT without
previous cryoprotection and bioengineered tissues preincubated in different volatile agents for different times and embedded in OCT.
Preincubation solution Average Average Standard Standard Fold-change Fold-change Area p value Diameter p value
area diameter deviation area deviation diameter area diameter vs. control vs. control
Paraffin-Embedding (Control) 44.4 7.2 25.2 2.3 1.0 1.0 - -
No Peincubation (OCT only) 8557.7 95.5 7273.9 44.4 192.7 13.3 0.000 0.000
Acetone 14320.5 130.8 7392.3 35.3 322.5 18.2 0.000 0.000
Glacial Acetic Acid 20155.2 145.5 21185.1 70.7 453.9 20.2 0.000 0.000
Formaldehyde 15841.3 138.1 8017.4 35.1 356.7 19.2 0.000 0.000
Glutarhaldehyde 16344.1 141.0 7528.8 32.1 368.1 19.6 0.000 0.000
The average area and diameter correspond to the interfibrillar spaces that appear in the fiber mesh after cryosectioning and staining. Fold-change area
corresponds to the ratio of the average area for each specific condition versus area of the paraffin-embedded control tissues. Fold-change diameter
corresponds to the ratio of the average diameter for each specific condition versus diameter of the paraffin-embedded control tissues.
Fig. 1. Histological analysis of formalin-fixed paraffin-embedded
bioengineered human tissues -control samples- (A), tissues embedded
in OCT without any previous treatment (B), samples pretreated with
acetone (C), glacial acetic acid (D), formaldehyde (E) or glutaraldehyde
(F) and embedded in OCT. H&E staining. Scale bars: 1 µm.
concentrations of glucose. The average area and
diameter of the spaces in the different concentrations of
glucose 120 min were 7905.2 µ m2 and 94.3 µ m
respectively, ranging between 5895.6±2242.3 µm2 and
11928.3±10423.4 µ m2 for the area, and between
84.8±15.7µm and 116.4±50.5 µm for the diameter.
Differences with the control samples were statistically
significant at all concentrations of glucose (p<0.001)
(Table 2). Ilustrative examples of bioengineered tissues
processed with these techniques are shown in Figure 2.
Maltose
When the artificial tissues were incubated in
different maltose solutions for 30 min, we found that the
consistency of the tissues was appropriate when 0.080M,
0.100M, 0.200M, 0.300M and 0.400M maltose was
used, being very low for lower concentrations of
maltose. In general, samples presented middle-size and
smaller spaces among the mesh fibers whose areas
ranged between 91.8±74.2 µm2 and 9460.2±12255.0
µm2, and whose diameters ranged between 9.9±4.3 µm
and 108.7±57.5 µm, with an average area and diameter
of 3402.5±3724.2 µm2 and 51.2±34.5 µm respectively.
Statistical comparison of both the areas and diameters of
tissues pretreated with maltose for 30 min with the
1534
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Table 2. Results of the histological analysis of human artificial tissues preincubated in different concentrations of glucose for different times and
embedded in OCT.
Preincubation Preincubation Average Average Standard Standard Fold-change Fold-change Area p value Diameter p value
time concentration area (µm2) diameter (µm) deviation area deviation diameter area diameter vs. control vs. control
30 min 0.002M 16665.6 139.8 10575.7 43 375.3 19.4 0.000 0.000
0.020M 16892.3 134.8 16745.9 61 380.4 18.7 0.000 0.000
0.050M 16522.1 135.7 11575.3 54.1 372.1 18.8 0.000 0.000
0.080M 21380 134.2 27634.5 101.2 481.5 18.6 0.000 0.000
0.100M 16401.3 133.6 12035.7 58.1 369.4 18.5 0.000 0.000
0.200M 22529.2 143.5 28962.7 94.8 507.4 19.9 0.000 0.000
0.300M 15094.2 135.8 6361.4 29.5 339.9 18.9 0.000 0.000
0.400M 16416.6 142.2 6318.7 27.7 369.7 19.7 0.000 0.000
60 min 0.002M 15636.6 129.8 14769.9 58.4 352.1 18 0.000 0.000
0.020M 16875.9 134.9 14345.9 60.5 380 18.7 0.000 0.000
0.050M 11516.3 114 8975.5 43.2 259.3 15.8 0.000 0.000
0.080M 13929.5 123.7 11251.5 51.9 313.7 17.2 0.000 0.000
0.100M 11574.8 108.9 12542.4 56.5 260.7 15.1 0.000 0.000
0.200M 10048.2 105.5 8460.7 42.9 226.3 14.7 0.000 0.000
0.300M 11153.4 112.6 7949 41.1 251.2 15.6 0.000 0.000
0.400M 6920.2 87.3 6669.9 36.5 155.8 12.1 0.000 0.000
120 min 0.002M 10295.2 104 10423.4 50.5 231.8 14.4 0.000 0.000
0.020M 11928.3 116.5 9143.5 42.5 268.6 16.2 0.000 0.000
0.050M 7123.4 87.8 6235.6 38.8 160.4 12.2 0.000 0.000
0.080M 7011.7 92.1 3428 22 157.9 12.8 0.000 0.000
0.100M 7298.4 91.5 5058.9 31.9 164.4 12.7 0.000 0.000
0.200M 6114.6 87 2242.4 15.7 137.7 12.1 0.000 0.000
0.300M 5895.7 84.8 2520.7 18.6 132.8 11.8 0.000 0.000
0.400M 7574.7 91.5 6105.3 37.7 170.6 12.7 0.000 0.000
The average area and diameter correspond to the interfibrillar spaces that appear in the fiber mesh after cryosectioning and staining. Fold-change area
corresponds to the ratio of the average area for each specific condition versus area of the paraffin-embedded control tissues. Fold-change diameter
corresponds to the ratio of the average diameter for each specific condition versus diameter of the paraffin-embedded control tissues.
among the mesh fibers, whose areas ranged between
15094.2±6361.4 µm2 and 22529.2±94.8 µm2, and whose
diameters ranged between 84.8±18.6 µm and 116.5±42.5
µ m, with an average area and diameter of
17737.7±2674.9 µm2 and 137.4±3.9 µm respectively.
Statistical comparison of both the areas and diameters of
tissues pretreated with glucose for 30 min with the
control samples showed statistically significant
differences for all concentrations (p<0.001). 
Secondly, when the tissues were incubated in
different glucose solutions for 60 min, we found that the
consistency of the tissues was appropriate when 0.200M,
0.300M or 0.400M glucose was used, being very low for
lower concentrations of glucose. Average area and
diameter of the spaces found in the artificial tissues
incubated for 60 min in the different concentrations of
glucose were 12206.9±3187.6 µm2 and 114.6±15.1 µm
respectively, ranging between 6920.2±6669.9 µm2 and
16875.9±14345.9 µ m2 for the area, and between
87.3±36.5 µm and 134.9±60.5 µm for the diameter.
Differences with the control samples were statistically
significant for all concentrations (p<0.001).
Finally, when the tissues were incubated for 120
min, we found that the consistency of the tissues was
appropriate when 0.100M, 0.200M, 0.300M or 0.400M
glucose was used, being very low for lower
control samples showed statistically significant
differences for all concentrations (p<0.001) except for
0.300M and 0.400M (p>0.001), being marginally
significant for 0.080M (p=0.001). 
Secondly, when the tissues were incubated in
different maltose solutions for 60 min, we found that the
consistency of the tissues was appropriate when maltose
0.080M, 0.100M, 0.200M, 0.300M and 0.400M was
used, being very low for 0.050, 0.020 and 0.002.
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Fig. 3. Histological analysis of bioengineered human tissues
preincubated in different concentrations of maltose for 30, 60 or 120 min
and embedded in OCT for cryosectioning and H&E staining. Scale bars:
1 µm.
Fig. 2. Histological analysis of bioengineered human tissues
preincubated in different concentrations of glucose for 30, 60 or 120 min
and embedded in OCT for cryosectioning and H&E staining. Scale bars:
1 µm.
Average area and diameter of the spaces found in the
artificial tissues incubated for 60 min in the different
concentrations of maltose were 7771.8±7225.8 µm2 and
81.2±43.9 µm respectively. Spaces found in samples
incubated in maltose for 60 min ranged between
537.3±515.2 µm2 and 21923.7±16473.2 µm2 for the
area, and between 23.8±11.2 µm and 158.2±70.4 µm for
the diameter. Differences with the control samples were
statistically significant (p<0.001).
Finally, when the tissues were incubated in different
maltose solutions for 120 min, the consistency of the
tissues was higher than for the tissues incubated in
maltose for 30 or 60 min, allowing cryosectioning and
mounting on microscope slides. Average area and
diameter of the spaces found in the artificial mesh of the
tissues incubated for 120 min were 1432.5±1392.0 µm2
and 33.3±18.6 µ m, respectively, ranging between
135.5±178.4 µm2 and 4040.7±4776.2 µm2 for the area,
and between 10.9±7.7µm and 62.9±36.1 µm for the
diameter. Differences with the control samples were
statistically significant (p<0.001) for samples incubated
in 0.002M, 0.020M, 0.050M and 0.080M, but not for
higher concentrations (p>0.001) (Table 3). llustrative
examples of bioengineered tissues preincubated in
maltose are shown in Figure 3.
Trehalose
Bioengineered human tissues incubated in trehalose
0.002M or 0.020M solutions for 30 min had very low
consistency, which was inappropriate for cryosection.
However, samples incubated in 0.050M, 0.080M,
0.100M, 0.200M, 0.300M or 0.400M trehalose for 30
min had proper consistency and were correctly
sectioned. In general, samples presented small spaces
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Table 3. Results of the histological analysis of human artificial tissues preincubated in different concentrations of maltose for different times and
embedded in OCT.
Preincubation Preincubation Average Average Standard Standard Fold-change Fold-change Area p value Diameter p value
time concentration area (µm2) diameter (µm) deviation area deviation diameter area diameter vs. control vs. control
30 min 0.002M 9460.3 108.7 2899.3 15.6 213.0 15.1 0.000 0.000
0.020M 9081.7 92.7 12255.0 57.5 204.5 12.9 0.000 0.000
0.050M 2255.6 44.6 3116.8 31.3 50.8 6.2 0.000 0.000
0.080M 2004.3 45.1 1744.1 24.1 45.1 6.3 0.000 0.000
0.100M 2006.5 50.1 555.7 7.3 45.2 7.0 0.000 0.000
0.200M 2135.6 46.3 2138.0 25.3 48.1 6.4 0.000 0.000
0.300M 184.9 12.6 274.7 9.2 4.2 1.8 0.000 0.000
0.400M 91.8 10.0 74.2 4.4 2.1 1.4 0.000 0.000
60 min 0.002M 21923.7 158.2 14291.7 56.6 493.7 22.0 0.000 0.000
0.020M 11254.2 109.2 12356.0 51.7 253.4 15.2 0.000 0.000
0.050M 12612.3 107.7 16473.2 70.4 284.0 15.0 0.000 0.000
0.080M 5277.4 77.2 3899.4 29.0 118.8 10.7 0.000 0.000
0.100M 6833.9 85.0 5666.4 40.6 153.9 11.8 0.000 0.000
0.200M 2367.2 50.2 2541.6 23.3 53.3 7.0 0.000 0.000
0.300M 1368.4 38.9 1264.9 16.0 30.8 5.4 0.000 0.000
0.400M 537.4 23.9 515.2 11.3 12.1 3.3 0.000 0.000
120 min 0.002M 4040.7 63.0 4776.3 36.2 91.0 8.7 0.000 0.000
0.020M 2494.4 47.3 3358.3 32.3 56.2 6.6 0.000 0.000
0.050M 2317.2 49.8 2341.6 22.9 52.2 6.9 0.000 0.000
0.080M 1082.5 32.2 1335.7 19.4 24.4 4.5 0.000 0.000
0.100M 835.9 29.5 808.6 14.8 18.8 4.1 0.063 0.063
0.200M 376.7 21.0 224.9 6.6 8.5 2.9 0.035 0.035
0.300M 177.3 13.1 197.2 7.8 4.0 1.8 0.063 0.063
0.400M 135.5 10.9 178.4 7.7 3.1 1.5 0.529 0.529
The average area and diameter correspond to the interfibrillar spaces that appear in the fiber mesh after cryosectioning and staining. Fold-change area
corresponds to the ratio of the average area for each specific condition versus area of the paraffin-embedded control tissues. Fold-change diameter
corresponds to the ratio of the average diameter for each specific condition versus diameter of the paraffin-embedded control tissues.
among the fiber mesh, whose mean area ranged between
33.4±34.0 µm2 and 4394.3.±6714.4 µm2 and whose
diameter ranged between 5.8±3.0 µm and 54.5±54.0 µm.
Average area and diameter were 1069.4±1526.3 µm2 and
22.6±17.8 µ m, respectively (Fig. 5). Statistical
comparisons of both the areas and diameters of tissues
pretreated with trehalose for 30 min with the control
samples did not show any statistically significant
differences (p 0.001). 
Secondly, when the tissues were incubated in
trehalose for 60 min, we found that the consistency of
the tissues was appropriate for cryosectioning
procedures at all concentrations. Average area and
diameter of the spaces found in the artificial tissues
incubated for 60 min in the different concentrations of
trehalose were 1023.7±1316.7 µm2 and 26.7±17.0 µm,
respectively, ranging between 127.4±107.7 µm2 and
3758.3±4385.9 µm2 for the area, and 60.3±35.6 µm and
11.7±5.1 µm for the diameter. Differences with the
control samples were statistically significant for 0.002M
and 0.020M trehalose (p<0.001), but not for higher
concentrations of trehalose.
Finally, when the tissues were incubated in different
trehalose solutions for 120 min, we found that the
consistency of the tissues was high, allowing for
cryosection, although the tissues became very hard and
cryosection was not easy. Average area and diameter of
the spaces found in the artificial tissues incubated for
120 min in trehalose were 1224.2±1125.2 µm2 and
28.6±16.0 µm respectively, ranging between 21.9±10.8
µ m2 and 3707.4±4988.4 µ m2 for the area, and
5.1±1.3µm and 56.7±40.8 µm for the diameter (Fig. 5).
Differences with the control samples were statistically
significant for 0.002M, 0.020M, 0.080M and 0.200M
trehalose (p<0.001) and marginally significant for
0.001M (p=0.001). No differences were found for the
rest of the concentrations of trehalose (Table 4).
Illustrative examples of the histological analysis of
artificial tissues preincubated in trehalose solutions are
shown in Figure 4.
Discussion
Construction of artificial tissues by tissue
engineering is a novel technique that allows for the in
vitro development of all kinds of human tissues with
potential clinical usefulness. Among others, different
researchers have reported the efficient creation of oral
mucosa, cornea, skin, cartilage, bone and muscle using
different biomaterials as stromal substitutes (Alaminos et
al., 2006, 2007; Moharamzadeh et al., 2007; Sanchez-
Quevedo et al., 2007; Escamez et al., 2008).
As an important part of the process of evaluation and
quality control of the bioengineered tissues, histological
analysis must be performed on all tissues generated in
the laboratory previously to their clinical implantation in
patients (Proussaefs et al., 2002). However, classical
histological methods and techniques must be optimized
for the novel tissues developed in the laboratory by
tissue engineering. In this milieu, handling and
processing of native tissues using OCT embedding and
cryosection in a cryostat microtome could be a difficult
technique even for experienced histotechnologists
(Franks, 1998), and no works have been reported on the
use of this method on artificial tissues.
In this context, there is a complete lack of
information related to the use of classical techniques
such as OCT embedding tissue cryosectioning applied to
bioengineered human tissues. For that reason, in this
work we have carried out an exploratory analysis of the
properties and structure of tissues submitted to different
methods and incubated in different cryoprotective
solutions prior to OCT cryosectioning. 
When tissues were tested using several volatile
fixing solutions of widespread use in histology and in
tissue bank protocols (Holund et al., 1981; Baum et al.,
1994) samples presented an inappropriate consistency
and the structure of the fiber mesh developed big spaces,
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Table 4. Results of the histological analysis of human artificial tissues preincubated in different concentrations of trehalose for different times and
embedded in OCT.
Preincubation Preincubation Average Average Standard Standard Fold-change Fold-change Area p value Diameter p value
time concentration area (µm2) diameter (µm) deviation area deviation diameter area diameter vs. control vs. control
30 min 0.002M 4394.4 54.5 6714.4 54.0 99.0 7.6 0.001 0.001
0.020M 2005.6 38.9 2535.5 33.9 45.2 5.4 0.089 0.089
0.050M 1392.6 34.3 1819.6 25.7 31.4 4.8 0.001 0.001
0.080M 343.6 15.8 538.7 14.4 7.7 2.2 0.315 0.315
0.100M 114.0 9.8 173.6 7.5 2.6 1.4 0.739 0.739
0.200M 226.4 15.4 193.9 7.6 5.1 2.1 0.009 0.009
0.300M 45.7 6.8 52.6 3.7 1.0 0.9 0.393 0.393
0.400M 33.4 5.8 34.1 3.1 0.8 0.8 0.280 0.280
60 min 0.002M 3758.3 60.3 4386.0 35.7 84.6 8.4 0.000 0.000
0.020M 2366.5 45.7 3311.3 32.0 53.3 6.3 0.000 0.000
0.050M 497.1 23.3 453.1 10.1 11.2 3.2 0.004 0.004
0.080M 364.0 17.3 472.6 13.5 8.2 2.4 0.035 0.035
0.100M 448.9 19.5 589.6 14.6 10.1 2.7 0.029 0.029
0.200M 338.0 19.8 203.7 6.5 7.6 2.8 0.075 0.075
0.300M 127.4 11.8 107.7 5.2 2.9 1.6 0.043 0.043
0.400M 289.6 16.1 377.3 11.0 6.5 2.2 0.023 0.023
120 min 0.002M 3707.5 56.7 4988.5 40.9 83.5 7.9 0.000 0.000
0.020M 1039.2 31.1 1188.6 20.0 23.4 4.3 0.000 0.000
0.050M 1191.0 28.9 2000.9 27.5 26.8 4.0 0.001 0.001
0.080M 1435.1 38.6 1197.0 19.4 32.3 5.4 0.000 0.000
0.100M 1197.5 26.3 2861.6 30.4 27.0 3.7 0.011 0.011
0.200M 1044.3 31.7 1198.5 18.9 23.5 4.4 0.000 0.000
0.300M 157.3 10.3 314.6 10.2 3.5 1.4 0.971 0.971
0.400M 21.9 5.1 10.8 1.3 0.5 0.7 0.029 0.029
The average area and diameter correspond to the interfibrillar spaces that appear in the fiber mesh after cryosectioning and staining. Fold-change area
corresponds to the ratio of the average area for each specific condition versus area of the paraffin-embedded control tissues. Fold-change diameter
corresponds to the ratio of the average diameter for each specific condition versus diameter of the paraffin-embedded control tissues.
being very different to the paraffin-embedded control
samples. For that reason, we can conclude that the use of
these compounds is not appropriate for cryosectioning
purposes and we therefore suggest that the artificial
tissues be embedded in a cryoprotective agent without
previous fixation.
In contrast, the use of several types of carbon
hydrates, including glucose, maltose and trehalose,
resulted in better levels of tissue consistency and
appropriate preservation of the tissue structure,
especially at certain concentrations and incubation times.
Different substances have been used so far as
cryoprotective solutions prior to cryofixation of native
tissues (Naber et al., 1992; Loken and Demetrick, 2005),
especially sucrose (Ljungberg and Johansson, 1993;
Whitlon et al., 2001) and trehalose (Norville et al.,
2007).
The results of our work demonstrated that
preincubation of the bioengineered human tissues in
glucose solutions for different times did not result in
proper tissue structure preservation. In general, samples
preincubated in glucose became partially unstructured,
with large empty spaces among the fibers of the scaffold
and a large number of artifacts in the slide preparations.
For that reason, we conclude that the use of this
oligosaccharide is not adequate for tissues intended for
OCT embedding and cryosectioning.
On the other hand, the use of maltose solutions as
cryoprotectant agents for artificial tissues revealed that
certain concentrations and incubation times of the
different maltose solutions efficiently protected the
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Fig. 5. Histograms representing the average areas (top panel) and
diameters (lower panels) of samples preincubated in different
concentrations of trehalose for different times and embedded in OCT.
Black bars correspond to standard errors, whereas dotted red lines
represent the average area and diameter of control samples embedded
in paraffin.
Fig. 4. Histological analysis of bioengineered human tissues
preincubated in different concentrations of trehalose for 30, 60 or 120
min and embedded in OCT for cryosectioning and H&E staining. Scale
bars: 1 µm.
 
artificial tissues and resulted in histological images that
were not significantly different to those obtained by
using standard paraffin-embedding techniques. In short,
when tissues were incubated in 0.300M and 0.400M
maltose solutions for 30 min, we found that the average
areas of the interfibrillar spaces of the fiber mesh were 2
to 4 times larger than those found in the control samples,
and diameters were around 1.5 fold larger than control
samples. These values were clearly lower than those
obtained when the artificial tissues were directly
embedded in OCT and cryosectioned (average areas
were 192.7 times higher than control samples and
average diameters were 13.3 times higher). In fact, the
statistical analysis revealed that the differences with the
control were not significant and, therefore, the size of
the spaces of the maltose-incubated tissues was
comparable to that of control tissues. In contrast, when
the artificial tissues were incubated in maltose for 60
min, statistically significant differences with the control
tissues were detected at all concentrations, suggesting
that this technique was not useful for the processing of
the bioengineered tissues. Finally, pretreatment of the
human artificial tissues with maltose solutions for 120
min revealed non-significant differences between the
control and samples incubated in 0.100M, 0.200M,
0.300M or 0.400M maltose. Of all these concentrations
of maltose, 0.400M resulted in small interfibrillar spaces
with an average area that was 3.1 times the area of the
controls, and a mean diameter of 1.5 times the controls.
For that reason, we conclude that the best results using
maltose preincubation were found for 120 min and
0.400M concentration of this disaccharide, at least for
the kind of tissues used in this work (small pieces of
fibrin-agarose scaffolds). To determine the effect of
these compounds on artificial tissues of larger volume, it
could be necessary to use higher volumes of
preincubation solutions. According to previous studies,
most of tissues can be efficiently fixed by immersing the
samples in a volume of fixing fluid corresponding to at
least 25 times the volume of the tissues (Dempster,
1960).
The third carbon hydrate that was tested in this work
was disaccharide trehalose. Trehalose can be found in
several species with high survival capabilities to
dehydration and desiccation, and it has been
demonstrated that this carbon hydrate can confer
resistance to desiccation and freezing of mammal cells
(Guo et al., 2000; Crowe et al., 2001). For that reason,
several researchers have used this compound for
cryoprotection of samples submitted to cryosectioning
for electron crystallographic structure analysis (Hirai et
al., 1999) and cryoprotection of freeze-dried native
human tissues (Nakamura et al., 2008). Consequently, in
this work we hypothesized that trehalose and other
related carbon hydrates could protect the bioengineered
tissues from damage during the cryofixation, OCT
embedding and cryosectioning, and therefore improve
the biological quality of the analyzed tissues. Our results
demonstrated that incubation of the artificial tissues for
30 min in all tested concentrations of trehalose resulted
in good tissue quality, especially at the higher
concentrations. In fact, statistical comparison of the
interfibrillar spaces of controls and tissues incubated in
trehalose for 30 min did not show any significant
differences, suggesting that the quality of both types of
tissues was similar. Strikingly, incubation of the samples
for 30 min in 0.300M trehalose resulted in interfibrillar
spaces whose area and diameter were virtually identical
to those found in paraffin-embedded control samples (no
differences were found for the area, whereas diameter of
trehalose-pretreated tissues was 0.9 times the diameter of
the controls). Similarly, the use of 0.400M trehalose
resulted in good tissue quality, with areas and diameters
being 0.8 times the area and diameter of the control
tissues. Then, if the tissues were incubated in trehalose
solutions for 60 min, statistically significant differences
were found in comparison to the control for the
concentrations of 0.002M and 0.020M, revealing that
this technique was not appropriate for tissue
cryosectioning. Finally, the results of the tissue
preincubation in trehalose for 120 min resulted in very
heterogeneous results, with the best results found for
0.300M and 0.400M trehalose. Pretreatment of the
tissues with 0.400M trehalose for 120 min was able to
efficiently exert cryoprotective functions, and the area
and diameter of the interfibrillar spaces found in the
tissue were even smaller than those obtained with the
use of classical paraffin embedding methods, and no
artifacts were generated in the tissues. Due to the fact
that samples were not fixed prior to their inclusion in
OCT, we would propose fixing these tissues immediately
after sectioning.
Accordingly, we can conclude that the use of
0.300M or 0.400M trehalose for 30 min is the technique
that is able to generate tissue fiber structures that are
more similar to the paraffin-embedded control tissues.
However, our results suggest that preincubation of the
artificial tissues in 0.400M trehalose for 120 min could
even improve the quality of the tissues in comparison
with the controls. For all those reasons, we would
recommend the use of any of these concentrations and
incubation times before OCT embedding of human
artificial tissues. 
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